References
- Andersen, P. K., M. G. Hansen, and J. P. Klein. 2004. Regression analysis of restricted mean survival time based on pseudo-observations. Lifetime Data Analysis 10:335–350.
- Bacon, M. C., V. von Wyl, C. Alden, G. Sharp, E. Robison, N. Hessol, S. Gange, Y. Barranday, S. Holman, K. Weber, and M. A. Young. 2005. The Women’s Interagency HIV Study: an observational cohort brings clinical sciences to the bench. Clinical and Diagnostic Laboratory Immunology 12:1013–1019.
- Chen, P. Y., and A. A. Tsiatis. 2001. Causal inference on the difference of the restricted mean lifetime between two groups. Biometrics 57:1030–1038.
- Fine, J. P., and R. J. Gray. 1999. A proportional hazards model for the subdistribution of a competing risk. Journal of the American Statistical Association 94:496–509.
- Fleming, T. R., and D. P. Harrington. 1991. Counting Processes and Survival Analysis. New York: Wiley.
- Graw, F., T. A. Gerds, and M. Schumacher. 2009. On pseudo-values for regression analysis in competing risks models. Lifetime Data Analysis 15:241–255.
- He, P., E. Frank, H. S. Thomas, and M. J. Zhang. 2016. A proportional hazards regression model for the subdistribution with covariates-adjusted censoring weight for competing risks data. Scandinavian Journal of Statistics 43:103–122.
- Klein, J. P. 2006. Modelling competing risks in cancer studies. Statistics in Medicine 25:1015–1034.
- Klein, J. P., and P. K. Andersen. 2005. Regression modeling of competing risks data based on pseudovalues of the cumulative incidence function. Biometrics 61:223–229.
- Klein, J. P., B. Logan, M. Harhoff, and P. K. Andersen. 2007. Analyzing survival curves at a fixed point in time. Statistics in Medicine 26:4505–4519.
- Liang, K. Y., and S. L. Zeger. 1986. Longitudinal data analysis using generalized linear models. Biometrika 73:13–22.
- Li, J. 1999. An application of lifetime models in estimation of expected length of stay in hospital with complexity and age adjustment. Statistics in Medicine 18:3337–3344.
- Pollard, D. 1990. Empirical Processes: Theory and Applications. Hayward, CA: Institute of Mathematical Statistics.
- Royston, P., and M. K. Parmar. 2011. The use of restricted mean survival time to estimate the treatment effect in randomized clinical trials when the proportional hazards assumption is in doubt. Statistics in Medicine 30:2409–2421.
- Schaubel, D. E., and G. Wei. 2011. Double inverse weighted estimation of cumulative treatment effects under nonproportional hazards and dependent censoring. Biometrics 67:29–38.
- Scheike, T. H., M. J. Zhang, and T. A. Gerds. 2008. Predicting cumulative incidence probability by direct binomial regression. Biometrika 95:205–220.
- Sun, L., J. Liu, J. Sun, and M. J. Zhang. 2006. Modeling the subdistribution of a competing risk. Statistica Sinica 16:1367–1385.
- Tian, L., L. Zhao, and L. J. Wei. 2014. Predicting the restricted mean event time with the subject’s baseline covariates in survival analysis. Biostatistics 15:222–233.
- Zhao, H., and A. A. Tsiatis. 1997. A consistent estimator for the distribution of quality adjusted survival time. Biometrika 84:339–348.
- Zhao, L., L. Tian, H. Uno, S. D. Solomon, M. A. Pfeffer, J. S. Schindler, and L. J. Wei. 2012. Utilizing the integrated difference of two survival functions to quantify the treatment contrast for designing, monitoring, and analyzing a comparative clinical study. Clinical Trials 9:570–577.
- Zhao, L., B. Claggett, L. Tian, H. Uno, M. A. Pfeffer, S. D. Solomon, L. Trippa, and L. J. Wei. 2016. On the restricted mean survival time curve in survival analysis. Biometrics 72:215–221.